Back

Fibrosis biomarkers as a predictive tool for clinical outcome in PLNR14Del patients

25 April 2021 (15:15 - 16:10)
Organised by:
Congress Presentation Part of: New diagnostic methods in EP III Noninvasive Diagnostic Methods EHRA Premium Access EHRA 2021

About the speaker

Photo
Ms Stephanie Van Der Voorn

University Medical Center Utrecht, Utrecht (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Prevalence and clinical characteristics of patients presenting with phase 4 atrioventricular block.
Doctor S. Bun (Nice, FR)
Abstract Slides Video
Presentation thumbnail
Could specific EKG markers identify a pharmacologically induced type 1 Brugada pattern? Insights from a large, single-centre cohort.
Doctor L. Barbonaglia (Vercelli, IT)
Abstract Slides Video
Presentation thumbnail
A novel non-invasive electrocardiographic imaging technique facilitates the preprocedural diagnostic workup of patients with infrequent ventricular arrhythmias
Mrs K. Lesina (Zwolle, NL)
Abstract Slides Video
Presentation thumbnail
Technical and electrophysiological aspects of multisite cardiac stimulation through the access of the middle cardiac vein
Mr A. Rosa Filho (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
The role of marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation.
Doctor K. Vlachos (Bordeaux, FR)
Abstract Slides Video

Access the full session

Session thumbnail
New diagnostic methods in EP III

The Event

Event poster

EHRA 2021

25 April 2021 15:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources